Danazol in autoimmune haemolytic anaemia
Danazol combined with prednisone in adult warm antibody autoimmune hemolytic anemia patients resulted in long-lasting responses in 80% of newly diagnosed and 60% of refractory/relapsed cases with minimal side effects.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (10)
- Danazol via openalex
- Danazol: endocrine consequences in healthy women via openalex
- Danazol for treatment of refractory autoimmune hemolytic anaemia via openalex
- Danazol therapy for autoimmune hemolytic anemia via openalex
- doi:10.1016/0002-9343(55)90193-5 via openalex
- doi:10.1016/0002-9343(67)90168-4 via openalex
- doi:10.1111/j.1445-5994.1987.tb01276.x via openalex
- W21071181 via openalex
- W6600817966 via openalex
- doi:10.1056/nejm198306093082306 via openalex
Cited by (5)
- Current treatment strategies in autoimmune hemolytic disorders 2015
- Immune Hemolysis: Diagnosis and Treatment Recommendations 2015
- Warm autoimmune hemolytic anemia: recent progress in understanding the immunobiology and the treatment 2010
- Hemolytic anemia due to warm autoantibodies 2007
- Management of Evans syndrome 2005
Source provenance
- openalex
- last seen: 2026-05-11T05:49:40.447239+00:00
- pubmed
- last seen: 2026-10-08T21:59:37.277143+00:00